Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-22

Clinical Trial Update: Bioequivalence of Two Formulations of Ondansetron in Healthy Adults (0869-106) [Phase 1]

View source ↗

Summary

A Phase 1 bioequivalence study comparing two ondansetron formulations in healthy adults, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chemotherapy-Induced Nausea and Vomiting | Phase 1 | Status: COMPLETED | Results posted: 2010-06-22